Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Enzyme Catalysis . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109251948B reveals enzymatic synthesis for D-erythrulose. Offers cost reduction and supply chain reliability for personal care chemical manufacturing.
Patent CN110283800A details a novel enzymatic route for α-ketoglutarate. Discover cost reduction in nutritional ingredients manufacturing and high-purity supply chain advantages.
Patent CN107557412B details a continuous immobilized enzyme method for NADPH synthesis, offering high purity and cost reduction in biopharmaceutical manufacturing.
Patent CN105112468A reveals multi-enzyme systems for chiral amine synthesis. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing with scalable biocatalysis.
Patent CN107557412A details immobilized enzyme catalysis for NADPH. Achieves high purity and cost reduction in pharmaceutical intermediates manufacturing with scalable processes.
Patent CN106086126A reveals immobilized enzyme method for glutathione. Offers high purity, ATP regeneration, and cost reduction for pharmaceutical intermediates manufacturing.
Patent CN110423717A reveals a novel multi-enzyme cascade for D-pantolactone. This report analyzes cost reduction and supply chain advantages for vitamin B5 intermediate manufacturing.
Patent CN108690836B details a mutated cyclohexanone monooxygenase for high-conversion esomeprazole synthesis, offering superior purity and scalability for API manufacturers.
Patent CN115678953A details a green enzymatic route for high-purity cholesterol, offering superior isomer control and safety for reliable pharmaceutical intermediate supply chains.
Patent CN121495896A reveals enhanced enzyme catalysis for chiral amine synthesis offering significant cost reduction and supply chain reliability for agrochemical manufacturing.
Patent CN101368199A details immobilized enzyme hydrolysis for high-purity D-amino acids. This green process ensures stable supply chain and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN117965653A reveals immobilized enzyme method for high-purity agrochemical intermediate manufacturing with reduced solvent burden and enhanced supply chain reliability.
Patent CN113264868B reveals an improved synthesis of 1-benzyl-3-piperidinol with superior stereoselectivity. Discover cost-effective manufacturing strategies for Benidipine intermediates.
Patent CN110714002B discloses a highly efficient nitrilase mutant for synthesizing (S)-3-cyano-5-methylhexanoic acid, offering superior stereoselectivity and solubility for scalable pharmaceutical manufacturing.
Patent CN112280755B reveals mutant enzyme technology for GHK tripeptide. Achieve high yield and purity with scalable enzymatic processes for cosmetic and pharma applications.
Patent CN115677456B reveals enzyme-catalyzed cannabidiol synthesis offering high purity and scalable manufacturing for global pharmaceutical supply chains.